Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of a class of nucleoside analogs in the preparation of drugs for preventing and/or treating cerebrovascular diseases

A drug and ischemic stroke technology, applied in the field of medicine, to achieve the effect of reducing neurological deficit score and infarct focus

Active Publication Date: 2022-07-08
LANZHOU UNIVERSITY
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Patent CN111741967A discloses nucleotide analogs, preparation methods and their applications in nucleic acid sequence determination, etc., which mainly relate to preparation methods of nucleoside analogs, etc.; patent CN109790196A discloses the use of reversibly blocked nucleoside analogs for nucleic acid detection Method; patent CN108671235A discloses a functional nucleic acid with nucleoside analog drugs integrated in its backbone and its derivatives and its preparation method, as well as the use of gene therapy and chemotherapy for combined treatment of diseases; patent CN104211742A discloses cyclophosphoryl Phosphoric acid N-fatty acid that is modified by the N-yl group and connected to the fatty chain is used for the treatment of viral hepatitis and liver cancer; patent CN110643609A discloses drug aptamers, preparation methods and applications of nucleoside analog drug molecules; however, At present, there is no literature on the application of nucleoside analogs to cerebrovascular diseases, nor any literature suggesting that nucleoside analogs have new uses for the treatment of cerebrovascular diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of a class of nucleoside analogs in the preparation of drugs for preventing and/or treating cerebrovascular diseases
  • Application of a class of nucleoside analogs in the preparation of drugs for preventing and/or treating cerebrovascular diseases
  • Application of a class of nucleoside analogs in the preparation of drugs for preventing and/or treating cerebrovascular diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Example 1. The therapeutic effect of lamivudine on ischemic stroke

[0048] 1. Laboratory animals and drugs

[0049] SPF grade healthy male SD rats, weighing 200-240g, have not used any drugs before the experiment, provided by Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, animal license number is SCXK (gan)-2020-0002, adaptive feeding for one week, Animals were given chow and water ad libitum and were then grouped for experiments.

[0050] Drugs and reagents: Lamivudine (Lamivudine, 3-TC, HPLC≥98%), purchased from McLean Biotechnology Co., Ltd.; Butylphthalide Soft Capsules (NBP, NBP), purchased from NBP of CSPC Pu Pharmaceutical Co., Ltd.; 2,3,5-triphenyltetrazolium chloride (TTC), purchased from Solarbio Company.

[0051] 2. Preparation and administration time of MCAO model: After one week of adaptive feeding, all SD rats were randomly divided into 4 groups, and the grouping and administration doses were as follows:

[0052] Sham ...

Embodiment 2

[0068] Example 2. Therapeutic effect of zidovudine and acyclovir on ischemic stroke

[0069] 1. Experimental animals

[0070] SPF grade healthy male SD rats, weighing 200-240g, have not used any drugs before the experiment, provided by Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, license number is SCXK (gan)-2020-0002, adaptive rearing for one week, given Animals were fed food and water ad libitum before being grouped for the experiment.

[0071] 2. Reagents and experimental methods

[0072] Drugs and reagents: Zidovudine (Zidovudine, AZT, HPLC≥98%), purchased from Aladdin Biotechnology Co., Ltd.; Acyclovir (Acyclovir, ACV, HPLC≥98%), purchased from McLean Biotechnology Co., Ltd. Company; Butylphthalide Soft Capsules (NBP, NBP), purchased from NBP Pharmaceutical Co., Ltd. of CSPC; 2,3,5-triphenyltetrazolium chloride (TTC), purchased from Solarbio Company .

[0073] 3. The preparation of the animal model and the method for detecting the i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicine, in particular to the application of nucleoside analogs in the preparation of medicines for preventing or treating cerebrovascular diseases. The general structural formula of the nucleoside analogs of the present invention is shown in formula (I), wherein X and Y are respectively selected from any one of S, O, NH or alkoxy, and R is limited to cytosine, thymine, Either adenine or guanine, R 1 For OH, NH 2 , CH 3 , CH 3 O, halogen, C 1 ‑C 6 Alkyl, metal ions, etc.; R 2 For OH, NH 2 , CH 3 , CH 3 O, halogen, C 1 ‑C 6 Alkyl, metal ions, etc.; 0≤n≤3. The nucleoside analog has significant curative effect on ischemic cerebral apoplexy, can significantly improve nerve function damage, reduce infarct size, and has a good clinical application prospect in clinic.

Description

technical field [0001] The present invention relates to the field of medical technology, and also relates to a class of novel small molecular compounds that can be used for cerebrovascular diseases, and more particularly to the preparation of nucleoside analogs such as lamivudine, zidovudine and acyclovir for cerebrovascular diseases. The use of drugs in vascular diseases. Background technique [0002] Cerebrovascular disease refers to various diseases of the brain blood vessels, including atherosclerosis, thrombosis, stenosis, occlusion, cerebral arteritis, cerebral artery injury, cerebral aneurysm, intracranial vascular malformation, cerebral aneurysm The common feature of venous fistula is to cause brain tissue ischemia or hemorrhagic accident. Typical cerebrovascular diseases include cerebral thrombosis, cerebral ischemia, and cerebral infarction. [0003] Cerebral thrombosis is based on cerebral atherosclerosis and plaque. Under the conditions of slow blood flow and l...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/513A61K31/7072A61K31/522A61P9/00A61P9/10A61P7/02A61P7/04A61P25/00
CPCA61K31/513A61K31/7072A61K31/522A61P9/00A61P9/10A61P7/02A61P7/04A61P25/00
Inventor 陈新平刘菁菁赵文阳
Owner LANZHOU UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com